353 related articles for article (PubMed ID: 3970930)
21. Endogenous ADP-ribosylation of elongation factor 2 in polyribosome fraction of rabbit reticulocytes.
Sitikov AS; Davydova EK; Ovchinnikov LP
FEBS Lett; 1984 Oct; 176(1):261-3. PubMed ID: 6092136
[TBL] [Abstract][Full Text] [Related]
22. Characterization of the endogenous ADP-ribosylation of wild-type and mutant elongation factor 2 in eukaryotic cells.
Fendrick JL; Iglewski WJ; Moehring JM; Moehring TJ
Eur J Biochem; 1992 Apr; 205(1):25-31. PubMed ID: 1313365
[TBL] [Abstract][Full Text] [Related]
23. Interaction of phosphorylated elongation factor EF-2 with nucleotides and ribosomes.
Dumont-Miscopein A; Lavergne JP; Guillot D; Sontag B; Reboud JP
FEBS Lett; 1994 Dec; 356(2-3):283-6. PubMed ID: 7805855
[TBL] [Abstract][Full Text] [Related]
24. Crystal structure of ADP-ribosylated ribosomal translocase from Saccharomyces cerevisiae.
Jørgensen R; Yates SP; Teal DJ; Nilsson J; Prentice GA; Merrill AR; Andersen GR
J Biol Chem; 2004 Oct; 279(44):45919-25. PubMed ID: 15316019
[TBL] [Abstract][Full Text] [Related]
25. Eukaryotic translation elongation factor 2 (eEF2) catalyzes reverse translocation of the eukaryotic ribosome.
Susorov D; Zakharov N; Shuvalova E; Ivanov A; Egorova T; Shuvalov A; Shatsky IN; Alkalaeva E
J Biol Chem; 2018 Apr; 293(14):5220-5229. PubMed ID: 29453282
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of protein synthesis by didemnin B: how EF-1alpha mediates inhibition of translocation.
Ahuja D; Vera MD; SirDeshpande BV; Morimoto H; Williams PG; Joullié MM; Toogood PL
Biochemistry; 2000 Apr; 39(15):4339-46. PubMed ID: 10757982
[TBL] [Abstract][Full Text] [Related]
27. On the mode of inhibition of eukaryotic protein synthesis by ADP-ribosylation of elongation factor 2.
Nurten R; Albeniz I; Bermek E
IUBMB Life; 1999 Nov; 48(5):557-62. PubMed ID: 10637774
[TBL] [Abstract][Full Text] [Related]
28. Active-site mutations of the diphtheria toxin catalytic domain: role of histidine-21 in nicotinamide adenine dinucleotide binding and ADP-ribosylation of elongation factor 2.
Blanke SR; Huang K; Wilson BA; Papini E; Covacci A; Collier RJ
Biochemistry; 1994 May; 33(17):5155-61. PubMed ID: 8172890
[TBL] [Abstract][Full Text] [Related]
29. Reduced puromycin sensitivity of translocated polysomes after the addition of elongation factor 2 and non-hydrolysable GTP analogues.
Nilsson L; Nygård O
FEBS Lett; 1992 Aug; 309(1):89-91. PubMed ID: 1511751
[TBL] [Abstract][Full Text] [Related]
30. Affinity labelling of the eukaryotic elongation factor EF-2 with the guanosine nucleotide analogue 5'-p-fluorosulfonylbenzoylguanosine.
Nilsson L; Nygård O
Biochim Biophys Acta; 1984 May; 782(1):49-54. PubMed ID: 6722159
[TBL] [Abstract][Full Text] [Related]
31. The mechanism of ADP-ribosylation of elongation factor 2 catalyzed by fragment A from diphtheria toxin.
Chung DW; Collier RJ
Biochim Biophys Acta; 1977 Aug; 483(2):248-57. PubMed ID: 196649
[TBL] [Abstract][Full Text] [Related]
32. Identification of the major Mr 100,000 substrate for calmodulin-dependent protein kinase III in mammalian cells as elongation factor-2.
Nairn AC; Palfrey HC
J Biol Chem; 1987 Dec; 262(36):17299-303. PubMed ID: 3693353
[TBL] [Abstract][Full Text] [Related]
33. Diphthamide in elongation factor 2: ADP-ribosylation, purification, and properties.
Bodley JW; Dunlop PC; VanNess BG
Methods Enzymol; 1984; 106():378-87. PubMed ID: 6387379
[No Abstract] [Full Text] [Related]
34. Structural and functional studies of the interaction of the eukaryotic elongation factor EF-2 with GTP and ribosomes.
Nilsson L; Nygård O
Eur J Biochem; 1988 Jan; 171(1-2):293-9. PubMed ID: 3338467
[TBL] [Abstract][Full Text] [Related]
35. Characterisation of the ribosomal binding site for eukaryotic elongation factor 2 by chemical cross-linking.
Nygård O; Nilsson L; Westermann P
Biochim Biophys Acta; 1987 Dec; 910(3):245-53. PubMed ID: 3676324
[TBL] [Abstract][Full Text] [Related]
36. Binding of aminoacyl-tRNA to ribosomes promoted by elongation factor Tu. Studies on the role of GTP hydrolysis.
Yokosawa H; Kawakita M; Arai K; Inoue-Yokosawa N; Kaziro Y
J Biochem; 1975 Apr; 77(4):719-28. PubMed ID: 1097432
[TBL] [Abstract][Full Text] [Related]
37. On the nature of cellular ADP-ribosyltransferase from rat liver specific for elongation factor 2.
Sayhan O; Ozdemirli M; Nurten R; Bermek E
Biochem Biophys Res Commun; 1986 Sep; 139(3):1210-4. PubMed ID: 3094526
[TBL] [Abstract][Full Text] [Related]
38. Cholera toxin action on rabbit corpus luteum membranes: effects on adenylyl cyclase activity and adenosine diphospho-ribosylation of the stimulatory guanine nucleotide-binding regulatory component.
Abramowitz J; Campbell AR
Biol Reprod; 1985 Mar; 32(2):463-74. PubMed ID: 3921075
[TBL] [Abstract][Full Text] [Related]
39. Primary structure of elongation factor 2 around the site of ADP-ribosylation is highly conserved from archaebacteria to eukaryotes.
Gehrmann R; Henschen A; Klink F
FEBS Lett; 1985 Jun; 185(1):37-42. PubMed ID: 3996598
[TBL] [Abstract][Full Text] [Related]
40. The pretranslocation ribosome is targeted by GTP-bound EF-G in partially activated form.
Hauryliuk V; Mitkevich VA; Eliseeva NA; Petrushanko IY; Ehrenberg M; Makarov AA
Proc Natl Acad Sci U S A; 2008 Oct; 105(41):15678-83. PubMed ID: 18836081
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
